CN1943682A - A Chinese traditional medicinal composition for treatment of hepatitis C - Google Patents
A Chinese traditional medicinal composition for treatment of hepatitis C Download PDFInfo
- Publication number
- CN1943682A CN1943682A CN 200610102100 CN200610102100A CN1943682A CN 1943682 A CN1943682 A CN 1943682A CN 200610102100 CN200610102100 CN 200610102100 CN 200610102100 A CN200610102100 A CN 200610102100A CN 1943682 A CN1943682 A CN 1943682A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- hepatitis
- root
- kilograms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
This invention provides a Chinese traditional medicinal composition-hepatitis C virus clearer. The composition is prepared by taking natural Chinese herbal ingredients as raw materials such like virgate wormwood herb, Chinese thorowax root, membranous milkvetch root, danshen root, gentian root, indigo woad root, indian bread, umbellate pore fungus, oriental waterplantain rhizome, safflower, dandelion herb, pilose asiabell root, common peony root, lobed kudzuvine root, chuanxiong ligusticum rhizome, barbary solfberry fruit, laikal skullcap root, stringy stonecrop herb and hawthorn fruit. The Chinese traditional medicine is coming from the clinical descriptions. 10 years of observations shows that it has the following characters in treating hepatitis C as compared with the existing treating technologies: Its curative effectiveness is far higher than that of the interferon,its curative ratio is above 60%. As for those hepatitis C patients who's HCV-RNA would not transfer to negative or non rebounding, his HCV-RNA can still transfer to negative when insist taking the hepatitis C virus clearer. The hepatitis C virus clearer is effective in treating low rebounding and still effective after rebounding is gained but insisting on taking the hepatitis C virus clearer. Side effect of the hepatitis C virus clearer is small, and its cost is lower than that of the interferons.
Description
(1) technical field
The present invention relates to a kind of Chinese patent medicine, particularly a kind of Chinese medicine composition that is used for the treatment of hepatitis C is commonly called as medicine for treating viral hepatitis C.
(2) background technology
Hepatitis C is classified as the world's ten big incurable diseases by international medical community, and its harm is to infect the patient of hepatitis C virus to have 50% to die from liver cirrhosis or hepatocarcinoma in 10 years.At present, the external medicine interferon therapy hepatitis C that adopt more, but big for patient's side effect, knock-on rate height costs an arm and a leg, and long term injections is brought very big misery to the patient, and effectively kill virus thereby cure rate are low.Domestic also spread the treatment various hepatopathys the Chinese patent medicine kind more, as Yiganling, middle imperial liver spleen health, LONGDAN XIEGAN WAN or the like, but Practical Performance is all not satisfactory.
(3) summary of the invention
The objective of the invention is to overcome the prior art deficiency, provide a kind of side effect little, expense is cheap, the Chinese medicine of being made by natural Chinese medicinal herb that can effectively treat hepatitis C.
The object of the present invention is achieved like this, by following drug weight compatibility: Herba Artemisiae Scopariae 10-20 part, Radix Bupleuri 5-15 part, Radix Astragali 10-15 part, Radix Salviae Miltiorrhizae 10-20 part, Radix Gentianae 7-12 part, Radix Isatidis 10-15 part, Poria 5-15 part, Polyporus 10-15 part, Rhizoma Alismatis 5-15 part, Flos Carthami 4-8 part, Herba Taraxaci 12-16 part, Radix Codonopsis 5-15 part, Radix Paeoniae Rubra 5-15 part, Radix Puerariae 5-15 part, Rhizoma Chuanxiong 5-15 part, Fructus Lycii 9-15 part, Radix Scutellariae 7-12 part, Herba Sedi 25-35 part, Fructus Crataegi 10-20 part.
Further, drug weight compatibility: 15 parts of Herba Artemisiae Scopariaes, 10 parts of Radix Bupleuri, 12 parts of the Radixs Astragali, 15 parts of Radix Salviae Miltiorrhizaes, 9 parts of Radix Gentianaes, 12 parts of Radix Isatidiss, 10 parts in Poria, 12 parts of Polyporus, 10 parts of Rhizoma Alismatis, 6 parts on Flos Carthami, 14 parts of Herba Taraxacis, 10 parts of Radix Codonopsis, 10 parts of Radix Paeoniae Rubra, 10 parts of Radix Puerariaes, 10 parts of Rhizoma Chuanxiongs, 12 parts of Fructus Lycii, 9 parts of Radix Scutellariaes, 30 parts of Herba Sedis, 15 parts of Fructus Crataegis.
Production method of the present invention is:
Drug ratio by above-mentioned Chinese medicine, get Herba Artemisiae Scopariae, Radix Bupleuri, the Radix Astragali, Radix Salviae Miltiorrhizae, Radix Gentianae, Radix Isatidis, Poria, Polyporus, Rhizoma Alismatis, Flos Carthami, Herba Taraxaci, Radix Codonopsis, Radix Paeoniae Rubra, Radix Puerariae, Rhizoma Chuanxiong, Fructus Lycii, Radix Scutellariae, Herba Sedi, Fructus Crataegi, above-mentioned flavor medicine is removed impurity, cleaning, immersion, extracting concentrated through modern advanced pharmaceutical technology, negative 50 degree cold drying are granulated promptly.
The present invention thinks like this, present hepatitis C that medical science is referred to as, and motherland's medical literature does not have this title, but with regard to its clinical findings sings and symptoms, can be summarized in the category of motherland's medical science " jaundice ", " hypochondriac pain ", its etiology and pathology is general many owing to eating and drinking without temperance, the delicious food of being addicted to drink, the heresy that diseases caused by exogenous pathogenic factor virus is damp and hot, it is impaired to cause spleen and stomach function, dysfunction of the spleen in transportation, retention of dampness in middle-JIAO accumulates and steams in liver and gall, and the liver failing to maintain the normal flow of QI, bile are excessive, impregnated in skin, dirty in bladder, form jaundice, liver and gall are hot and suffocating, and so functional activity of QI being not smooth is side of body distending pain.Pharmacology of the present invention is to be that point of penetration is come regulating functional activities of qi with the clearing heat and expelling damp, soothing liver and strengthening spleen, blood circulation promoting and blood stasis dispelling, improve the internal body environment, regulate immunity, improve and improve immunologic mechanism, focus on nervus centralis, parasympathetic nerve, endocrine, reticuloendothelial system, thereby the particularly improvement of cellular immunization and humoral immunization. suppress virus replication, reach the purpose of removing hepatitis C virus, the recovery from illness dead stroke in conjunction with the effect of heat-clearing and toxic substances removing medicine.Medicine for treating viral hepatitis C is to be integrated as theory with Chinese and western medicine, the preparation of the effective medicinal ingredient that from natural plants, extracts, and outward appearance is the crystalline particle shape.Medicine for treating viral hepatitis C belongs to domestic the first from clinical proved recipe, observed it through 10 years hepatitis C treatment is compared with prior art, and following characteristics are arranged: 1, curative effect is higher than efficacy of interferon therapy far away, and cure rate reaches more than 60%; 2, HCV-RNA does not turn out cloudy or knock-on person behind interferon therapy, takes medicine for treating viral hepatitis C and still can cloudyly change; 3, adhere to that treatment is still effective after the low and knock-on of medicine for treating viral hepatitis C treatment hepatitis C knock-on rate; 4, side effect is little; 5, expense is lower than the interferon therapy expense.
Function of the present invention with cure mainly: clearing away heat-damp and promoting diuresis, removing pathogenic heat from blood and toxic substance from the body, regulating liver-QI reason spleen.
Usage and consumption: oral, 2 times on the one, each 10-15 gram.
(4) specific embodiment
Embodiment 1: press routine proportioning and take by weighing raw material: 15 kilograms of Herba Artemisiae Scopariaes, 10 kilograms of Radix Bupleuri, 12 kilograms of the Radixs Astragali, 15 kilograms of Radix Salviae Miltiorrhizaes, 9 kilograms of Radix Gentianaes, 12 kilograms of Radix Isatidiss, 10 kilograms in Poria, 12 kilograms of Polyporus, 10 kilograms of Rhizoma Alismatis, 6 kilograms on Flos Carthami, 14 kilograms of Herba Taraxacis, 10 kilograms of Radix Codonopsis, 10 kilograms of Radix Paeoniae Rubra, 10 kilograms of Radix Puerariaes, 10 kilograms of Rhizoma Chuanxiongs, 12 kilograms of Fructus Lycii, 9 kilograms of Radix Scutellariaes, 30 kilograms of Herba Sedis, 15 kilograms of Fructus Crataegis.Above-mentioned flavor medicine is removed impurity, cleaning, immersion, concentrating through modern advanced pharmaceutical technology extraction, negative 50 degree cold drying are granulated promptly.
Embodiment 2: press routine proportioning and take by weighing raw material: 10 kilograms of Herba Artemisiae Scopariaes, 5 kilograms of Radix Bupleuri, 10 kilograms of the Radixs Astragali, 10 kilograms of Radix Salviae Miltiorrhizaes, 7 kilograms of Radix Gentianaes, 10 kilograms of Radix Isatidiss, 5 kilograms in Poria, 10 kilograms of Polyporus, 5 kilograms of Rhizoma Alismatis, 4 kilograms on Flos Carthami, 12 kilograms of Herba Taraxacis, 5 kilograms of Radix Codonopsis, Radix Paeoniae Rubra 5 are done gram, 5 kilograms of Radix Puerariaes, 5 kilograms of Rhizoma Chuanxiongs, 9 kilograms of Fructus Lycii, 7 kilograms of Radix Scutellariaes, 25 kilograms of Herba Sedis, 10 kilograms of Fructus Crataegis.Above-mentioned flavor medicine is removed impurity, cleaning, immersion, concentrating through modern advanced pharmaceutical technology extraction, negative 50 degree cold drying are granulated promptly.
Embodiment 3: 20 kilograms of Herba Artemisiae Scopariaes, 15 kilograms of Radix Bupleuri, 15 kilograms of the Radixs Astragali, 20 kilograms of Radix Salviae Miltiorrhizaes, 12 kilograms of Radix Gentianaes, 15 kilograms of Radix Isatidiss, 15 kilograms in Poria, 15 kilograms of Polyporus, 15 kilograms of Rhizoma Alismatis, 8 kilograms on Flos Carthami, 16 kilograms of Herba Taraxacis, 15 kilograms of Radix Codonopsis, 15 kilograms of Radix Paeoniae Rubra, 15 kilograms of Radix Puerariaes, 15 kilograms of Rhizoma Chuanxiongs, 15 kilograms of Fructus Lycii, 12 kilograms of Radix Scutellariaes, 35 kilograms of Herba Sedis, 20 kilograms of Fructus Crataegis.Above-mentioned flavor medicine is removed impurity, cleaning, immersion, concentrating through modern advanced pharmaceutical technology extraction, negative 50 degree cold drying are granulated promptly.
Claims (2)
1. Chinese medicine composition that is used for the treatment of hepatitis C is characterized in that by following drug weight compatibility:: Herba Artemisiae Scopariae 10-20 part, Radix Bupleuri 5-15 part, Radix Astragali 10-15 part, Radix Salviae Miltiorrhizae 10-20 part, Radix Gentianae 7-12 part, Radix Isatidis 10-15 part, Poria 5-15 part, Polyporus 10-15 part, Rhizoma Alismatis 5-15 part, Flos Carthami 4-8 part, Herba Taraxaci 12-16 part, Radix Codonopsis 5-15 part, Radix Paeoniae Rubra 5-15 part, Radix Puerariae 5-15 part, Rhizoma Chuanxiong 5-15 part, Fructus Lycii 9-15 part, Radix Scutellariae 7-12 part, Herba Sedi 25-35 part, Fructus Crataegi 10-20 part.
2. according to the Chinese medicine composition of the described treatment hepatitis C of claim 1, it is characterized in that following drug weight compatibility: 15 parts of Herba Artemisiae Scopariaes, 10 parts of Radix Bupleuri, 12 parts of the Radixs Astragali, 15 parts of Radix Salviae Miltiorrhizaes, 9 parts of Radix Gentianaes, 12 parts of Radix Isatidiss, 10 parts in Poria, 12 parts of Polyporus, 10 parts of Rhizoma Alismatis, 6 parts on Flos Carthami, 14 parts of Herba Taraxacis, 10 parts of Radix Codonopsis, 10 parts of Radix Paeoniae Rubra, 10 parts of Radix Puerariaes, 10 parts of Rhizoma Chuanxiongs, 12 parts of Fructus Lycii, 9 parts of Radix Scutellariaes, 30 parts of Herba Sedis, 15 parts of Fructus Crataegis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200610102100 CN1943682A (en) | 2006-10-30 | 2006-10-30 | A Chinese traditional medicinal composition for treatment of hepatitis C |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200610102100 CN1943682A (en) | 2006-10-30 | 2006-10-30 | A Chinese traditional medicinal composition for treatment of hepatitis C |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1943682A true CN1943682A (en) | 2007-04-11 |
Family
ID=38043476
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200610102100 Pending CN1943682A (en) | 2006-10-30 | 2006-10-30 | A Chinese traditional medicinal composition for treatment of hepatitis C |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1943682A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106075149A (en) * | 2016-07-30 | 2016-11-09 | 肖丽芳 | A kind of Chinese medicine composition treating hepatitis C |
| CN109833440A (en) * | 2017-11-24 | 2019-06-04 | 徐彩玲 | A kind of formula for treating hepatitis |
-
2006
- 2006-10-30 CN CN 200610102100 patent/CN1943682A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106075149A (en) * | 2016-07-30 | 2016-11-09 | 肖丽芳 | A kind of Chinese medicine composition treating hepatitis C |
| CN109833440A (en) * | 2017-11-24 | 2019-06-04 | 徐彩玲 | A kind of formula for treating hepatitis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102327569B (en) | Preparation method and application method of drug and herbal medicine thereof for curing chronic hepatitis B | |
| CN1814211A (en) | Chinese herbal medicine decoction for treating acute icterohepatitis and preparing method | |
| CN1062157C (en) | Hepatitis B curing toxin-dissipating pill | |
| CN1692939A (en) | Traditional Chinese medicine pill for treating hepatitis B, and its prepn. method | |
| CN101274044A (en) | Medicament for preventing and treating fatty liver and method of preparing the same | |
| CN104083727A (en) | Traditional Chinese medicine composition for nourishing and protecting liver | |
| CN1475229A (en) | Antifatigue compound Chinese medicine prescription and its preparation method | |
| CN1145240A (en) | Medicinal compsn. for prevention of Aids virus and cancer | |
| CN105125666A (en) | Traditional Chinese medicine foot bath preparation prepared by utilizing microbial fermentation and preparation method thereof | |
| CN102847061B (en) | Traditional Chinese medicine preparation for treating pediatric viral myocarditis and preparation method thereof | |
| CN1232288C (en) | Chinese medicine aqueous pill preparation for treating hepatitis B and its preparation process | |
| CN103142920A (en) | Traditional Chinese medicine composition for treating hepatitis B and preparation method thereof | |
| CN1879853A (en) | A medicinal liquor for treating qi-stagnant damp-obstruction type cirrhosis ascites and method for preparing same | |
| CN1943682A (en) | A Chinese traditional medicinal composition for treatment of hepatitis C | |
| CN102228648B (en) | Chinese medicinal composition for treating icterohepatitis | |
| CN101468178A (en) | Medicament composition for treating fatty liver and preparation method thereof | |
| CN1385191A (en) | Medicine for treating liver disease | |
| CN1393255A (en) | Medicine for treating viral hepatitis C | |
| CN100518800C (en) | Medicinal composition for treating hepatitis B | |
| CN1165691A (en) | Cream for relieving cough and asthma | |
| CN104258291A (en) | Chinese herbal medicine health oral liquid for preventing and treating alcoholic liver disease and fatty liver disease | |
| CN1241591C (en) | Taiyi liver protection capsule and its preparing method | |
| CN102784353A (en) | Medicament for treating hepatic cirrhosis ascites | |
| CN1340353A (en) | Orally-applied medicine for treating hepatism and its preparing process | |
| CN1352966A (en) | Medicine for treating tracheitis and asthma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |